Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Katarzyna Paal

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|May 8, 2023
Katarzyna Paal, Thomas Brunner
World Journal of Urology|December 18, 2024
Radiotherapy and inflammaging: the influence of prostate cancer radiotherapy on systemic inflammationKatarzyna Paal, Bettina Stranz, Eva-Maria Thurner, et al.
Clinical Chemistry and Laboratory Medicine|April 17, 2026
Mitochondrial DNA copy number in leukocytes predicts long-term survival in prostate cancerTanja Langsenlehner, Katarzyna Paal, Eva-Maria Thurner, et al.
Scientific Reports|January 21, 2026
Leukocyte telomere attrition following radiotherapy in prostate cancer: a prospective studyTanja Langsenlehner, Katarzyna Paal, Eva- Maria Thurner, et al.
Diagnostics (Basel, Switzerland)|February 25, 2023
The Pre-Treatment Platelet-to-Lymphocyte Ratio as a Prognostic Factor for Loco-Regional Control in Locally Advanced Rectal CancerRichard Partl, Katarzyna Paal, Bettina Stranz, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|September 2, 2023
Comprehensive geriatric assessment predicts radiation-induced acute toxicity in prostate cancer patientsKatarzyna Paal, Bettina Stranz, Eva-Maria Thurner, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|May 8, 2023
Katarzyna Paal, Thomas Brunner
World Journal of Urology|December 18, 2024
Radiotherapy and inflammaging: the influence of prostate cancer radiotherapy on systemic inflammationKatarzyna Paal, Bettina Stranz, Eva-Maria Thurner, et al.
Clinical Chemistry and Laboratory Medicine|April 17, 2026
Mitochondrial DNA copy number in leukocytes predicts long-term survival in prostate cancerTanja Langsenlehner, Katarzyna Paal, Eva-Maria Thurner, et al.
Scientific Reports|January 21, 2026
Leukocyte telomere attrition following radiotherapy in prostate cancer: a prospective studyTanja Langsenlehner, Katarzyna Paal, Eva- Maria Thurner, et al.
Diagnostics (Basel, Switzerland)|February 25, 2023
The Pre-Treatment Platelet-to-Lymphocyte Ratio as a Prognostic Factor for Loco-Regional Control in Locally Advanced Rectal CancerRichard Partl, Katarzyna Paal, Bettina Stranz, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|September 2, 2023
Comprehensive geriatric assessment predicts radiation-induced acute toxicity in prostate cancer patientsKatarzyna Paal, Bettina Stranz, Eva-Maria Thurner, et al.
Pageof 1